CORona Drug InTEractions database

Neomycin

Synonyms: Neo-rx

Description:

Neomycin is an aminoglycoside antibiotic found in many topical medications such as creams, ointments, and eyedrops. Neomycin belongs to aminoglycoside class of antibiotics that contain two or more amino sugars connected by glycosidic bonds.

PubChem: 8378

DrugBank: DB00994

ATC: A01AB08

Related interactions

Target	Drug	Type	Result
3C-like protease	Neomycin
Unspecific	Neomycin

Related publications

Title	Author	Type
Drug repurposing studies targeting SARS-nCoV2: An ensemble docking approach on drug target 3C-like protease (3CLpro)	Shruti Koulgi, Vinod Jani, Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, A. K. Nath, Hemant Darbari, Rajendra Joshi
Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19	Douglas Ferreira Sales-Medina, Ludmila Rodrigues Pinto Ferreira, Lavínia M. D. Romera, Karolina Ribeiro Gonçalves, Rafael V. C. Guido, Gilles Courtemanche, Marcos S. Buckeridge, Édison L. Durigon, Carolina B. Moraes, Lucio H. Freitas-Junior
Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents	Mohammad Z. Ahmed, Qamar Zia, Anzarul Haque, Ali S. Alqahtani, Omar M. Almarfadi, Saeed Banawas, Mohammed S. Alqahtani, Keshav L. Ameta, Shafiul Haque

Target	Target affiliation	Drug	Type	Result
Target	Target affiliation	Drug	Type	Result

Name	Synonyms	Genes	Origin
Name	Synonyms	Genes	Origin

Name	Synonyms	PubChem	DrugBank	RCSB PDB	ATC
Name	Synonyms	PubChem	DrugBank	RCSB PDB	ATC

Title	Authors	DOI	Source	Article type	Date
Title	Authors	DOI	Source	Article type	Date

Title	Status	Phases	Start Date	Prim. Comp. Date	Comp. Date	First Post. Date
Title	Status	Phases	Start Date	Prim. Comp. Date	Comp. Date	First Post. Date

CORDITE (CORona Drug InTEractions database) collects and aggregates data from PubMed, MedRxiv, BioRxiv, ChemRxiv and PMC for SARS-CoV-2. Its main focus is set on drug interactions either addressing viral proteins or human proteins that could be used to treat COVID. It collects and provides up-to-date information on computational predictions, in vitro, as well as in vivo study data.

The information provided is for research only and we cannot guarantee the correctness of the data.

Please contact dominik.heider@uni-muenster.de for further information.

Programmable access

There is an open API for access programmatically to the database. The API will print a JSON output:

Interactions

https://cordite-api.uni-muenster.de/api.php?action=list&table=interaction

Targets

https://cordite-api.uni-muenster.de/api.php?action=list&table=target

Drugs

https://cordite-api.uni-muenster.de/api.php?action=list&table=drug

Publications

https://cordite-api.uni-muenster.de/api.php?action=list&table=publication

Clinical trials

https://cordite-api.uni-muenster.de/api.php?action=list&table=clinical_trial